MedTrace Logo

Avacostar - (PASS)

NCT05897684 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2025-01-31

No results posted yet for this study

Summary

The Avacostar PASS is a non-interventional, multi-national, prospective cohort study that will collect data from 2 cohorts of patients: those treated with avacopan for active severe AAV, and a second cohort treated with a cyclophosphamide or rituximab-based induction regimen without avacopan for active severe AAV. The overall study duration is anticipated to be up to 7 years, including a recruitment period of approximately 3 years.

Conditions

  • ANCA-associated Vasculitis

Sponsors & Collaborators

  • Vifor Fresenius Medical Care Renal Pharma

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-11
Primary Completion
2030-12-01
Completion
2030-12-01

Countries

  • Germany
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05897684 on ClinicalTrials.gov